comparemela.com

Latest Breaking News On - தொழிற்சங்கம் இரசாயன - Page 2 : comparemela.com

COVID-19 crisis: Centre increases import of Tocilizumab injection amid high demand

COVID-19: Govt increases import of Tocilizumab injection amid high demand in country

COVID-19: Govt increases import of Tocilizumab injection amid high demand in country ANI | Updated: May 14, 2021 11:18 IST By Amit Kumar New Delhi [India], May 14 (ANI): As many as 30,000 vials of Tocilizumab, a drug often prescribed by doctors to treat COVID-19 patients, were imported to India within 11 days by the Central government to cater to the increasing demand across the country due to rising cases. Sources of the Union Chemical and Fertilisers Ministry told ANI that 30,000 vials were imported from April 30 to May 11. Tocilizumabinjection is manufactured by the Roche Company of Switzerland and imported and marketed by Cipla Ltd in India. They also informed that Tocilizumabinjection is primarily used for Rheumatoid Arthritis patients and the monthly import of this injection used to be around 1,700 vials and India is entirely dependent on imports for this drug.

Production capacity of Remdesivir ramped up to 90 lakh vials per month: Mansukh Mandaviya

Production capacity of Remdesivir ramped up to 90 lakh vials per month: Mansukh Mandaviya ANI | Updated: Apr 23, 2021 22:49 IST New Delhi [India], April 23 (ANI): Amid a shortage of Remdesivir in hospitals all over the country, Union Chemical and Fertilizer Minister Mansukh Mandaviya on Friday that 25 new manufacturing sites for the production of the anti-viral drug have been approved by the government and production capacity has now been ramped up to 90 lakh vials per month. Since 12th April, 25 new manufacturing sites for #Remdesivir s production have been approved. Production capacity is now ramped up to >=90 lakhs vials per month. Earlier it was 40 lakhs vials/month, Union Minister Mandaviya tweeted.

亚光科技:亚光科技集团股份有限公司发行股份购买资产并募集配套资金暨关联交易之限售股份解禁的核查意见- CFi CN 中财网

亚光科技:亚光科技集团股份有限公司发行股份购买资产并募集配套资金暨关联交易之限售股份解禁的核查意见- CFi CN 中财网
cfi.net.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cfi.net.cn Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.